Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dollar Tree, Inc. (DLTR) vs DexCom, Inc. (DXCM) Price & Performance

Dollar Tree, Inc.Trade
DexCom, Inc.Trade

Price performance (Past 24H)

Key statistics

Dollar Tree, Inc. vs DexCom, Inc. — how do they compare? Dollar Tree, Inc. trades at $118.58 (market cap $22.26B), while DexCom, Inc. trades at $84.38 (market cap $31.86B). The key difference: DexCom, Inc. is the larger of the two by market cap, and DexCom, Inc. is trading nearer its 52-week high, Dollar Tree, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Dollar Tree, Inc. for 58 Days and DexCom, Inc. for 62 Days on average.

DLTRDXCM
Market Cap
$22.26B$31.86B
Volume
2,317,4283,607,070
Sector
Consumer StaplesHealth
52-Week High
$141.21$92.34
52-Week Low
$86.80$54.84
Typical Hold Time
58 Days62 Days
Enterprise Value
$28.87B$31.32B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dollar Tree, Inc.

Dollar Tree (DLTR) trades at $116.3, up slightly by 0.09% on the day, with a bullish technical signal and strong analyst support. The stock shows robust earnings beats in recent quarters, with Q2 2026 EPS of $2.70 significantly exceeding the $1.15 estimate. Revenue for 2025 was $17.58 billion, though net income was negative due to a large tax expense, while 2026 projections indicate a return to profitability. Strategic initiatives like store expansions and a multi-price strategy are driving growth, supported by positive institutional buying activity.

The outlook for DLTR is positive, with a consensus price target of $139.33 offering ~20% upside. Key opportunities include continued earnings momentum and market share gains, but risks involve margin pressures from tariffs and rising costs. Investors should weigh the strong ROE of 45.87% against volatility in net income and competitive discount retail dynamics.

DexCom, Inc.

DXCM trades at $84.3, up 1.09% today, with a bearish technical signal but strong fundamentals. Revenue grew to $4.66B in 2025, with net income of $836.3M and a 17.93% margin. The stock has a P/E of 33.32 and P/S of 6.74. Recent news highlights growth in CGM adoption for Type 2 diabetes. Analyst consensus is bullish with an average price target of $95.07, supported by 42 buy ratings.

Outlook remains positive due to earnings beats and market expansion, but risks include competition and reimbursement challenges. The stock offers growth potential, yet investors should monitor execution against high valuations and technical resistance near $85.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DLTR

No sentiment data available yet.

DXCM
100% Buy0% Sell
Avg holding period · 62 Days

Top news

Latest headlines on both assets

About Dollar Tree, Inc.

Dollar Tree operates discount stores in the U.S. and Canada, including 8,647 shops under its namesake banner and 8,016 Family Dollar units (as of the end of fiscal 2021). The eponymous chain features branded and private-label goods, generally at a $1.25 price. Around 45% of Dollar Tree stores' fiscal 2021 sales came from consumables (including food, health and beauty, and household paper and cleaning products), nearly 50% from variety items (including toys and housewares), and just over 5% from seasonal goods. Family Dollar features branded and private-label goods at prices generally ranging from $1 to $10, with over 76% of fiscal 2021 sales from consumables, 9% from seasonal/electronic items (including prepaid phones and toys), 8% from home products, and 6% from apparel and accessories.

Read more on DLTR →

About DexCom, Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.

Read more on DXCM →